SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on May 5, 2021. The report discloses a material agreement entered into by the company regarding its Curation Foods business operations.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than financial performance data.
Material Changes
- New Strategic Agreement: Landec Corporation entered into a transportation management, warehousing, and transportation services agreement with Castellini Company LLC.
- Scope: The agreement specifically covers the operations of the company's Curation Foods business.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the disclosure of the new agreement. The press release detailing the agreement is included as Exhibit 99.1 but is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the terms and duration of the agreement with Castellini Company LLC in the attached press release (Exhibit 99.1).
- Confirm the impact of this logistics agreement on the cost structure of the Curation Foods business.
- Note that the registrant is Landec Corporation (Ticker: LNDC), not Lifecore Biomedical, Inc.